SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.87+1.3%Feb 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tharos who wrote (11360)8/18/1999 12:45:00 AM
From: Bluegreen  Read Replies (2) of 17367
 
Tharos, the FDA prefers information to be released at scientific presentations. I'm sure Xoma can say what ever they want at anytime BUT is it prudent and smart? One last thing I will also ask WHAT REGULATORY AGENCY PROOF READ XOMA'S PRESS RELEASE BEFORE IT WAS SENT OVER THE WIRES? This is just a sample of what you can find out IF you are willing to spend some time talking to the company. There are SO many things that go with this being the FIRST or nearly the FIRST BIOLOGICAL before the FDA with subpart E designation. My opinion is DON'T go by past or compare apples to oranges.....we are actually seeing history being made with this drug and its approach toward FDA approval. DON'T assume anything in this process, if you have questions just ask XOMA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext